medigraphic.com
ISSN 3061-8142 (Digital)

2026, Número S1

<< Anterior Siguiente >>

Rev Mex Anest 2026; 49 (S1)


Más allá del hígado: impacto de la disfunción renal en cirugía hepática mayor y trasplante hepático

Baptista W

Idioma: Español
Referencias bibliográficas: 10
Paginas: 217-219
Archivo PDF: 778.67 Kb.


FRAGMENTO

INTRODUCCIÓN

La lesión renal aguda (LRA) perioperatoria en cirugía hepática mayor y trasplante hepático es frecuente, silenciosamente letal y a menudo subdiagnosticada. Un metaanálisis de 33 estudios estimó la incidencia ponderada en trasplante de 40.8%, con 7% requiriendo terapia de reemplazo renal (TRR) y asociación significativa con mortalidad y falla del injerto.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Thongprayoon C, Kaewput W, Thamcharoen N, Bathini T,Watthanasuntorn K, Lertjitbanjong P, et al. Incidence and impact ofacute kidney injury after liver transplantation: a meta-analysis. J ClinMed. 2019;8:372. doi: 10.3390/jcm8030372.

  2. Hilmi IA, Damian D, Al-Khafaji A, Planinsic R, Boucek C, Sakai T,et al. Acute kidney injury following orthotopic liver transplantation:incidence, risk factors, and effects on patient and graft outcomes. Br JAnaesth. 2015;114:919-926. doi: 10.1093/bja/aeu556.

  3. Nadim MK, Kellum JA, Forni L, Francoz C, Asrani SK, OstermannM, et al. Acute kidney injury in patients with cirrhosis: Acute DiseaseQuality Initiative (ADQI) and International Club of Ascites (ICA) jointmultidisciplinary consensus meeting. J Hepatol. 2024;81:163-183. doi:10.1016/j.jhep.2024.03.031.

  4. KDIGO AKI Work Group. KDIGO clinical practice guideline for acutekidney injury. Kidney Int Suppl. 2012;2:1-138.

  5. Joliat GR, Kobayashi K, Hasegawa K, Thomson JE, Padbury R, ScottM, et al. Guidelines for perioperative care for liver surgery: EnhancedRecovery After Surgery (ERAS) Society recommendations 2022. WorldJ Surg. 2023;47:11-34. doi: 10.1007/s00268-022-06732-5.

  6. Myles PS, Bellomo R, Corcoran T, Forbes A, Peyton P, Story D, et al.Restrictive versus liberal fluid therapy for major abdominal surgery. NEngl J Med. 2018;378:2263-2274. doi: 10.1056/NEJMoa1801601.

  7. Nasralla D, Coussios CC, Mergental H, Akhtar MZ, Butler AJ, CeresaCDL, et al. A randomized trial of normothermic preservation in livertransplantation. Nature. 2018;557:50-56. doi: 10.1038/s41586-018-0047-9.

  8. van Rijn R, Schurink IJ, de Vries Y, van den Berg AP, Cortes CerisueloM, Darwish Murad S, et al. Hypothermic machine perfusion in livertransplantation — a randomized trial. N Engl J Med. 2021;384:1391-1401. doi: 10.1056/NEJMoa2031532.

  9. STARRT-AKI Investigators; Canadian Critical Care Trials Group;Australian and New Zealand Intensive Care Society Clinical TrialsGroup; United Kingdom Critical Care Research Group; CanadianNephrology Trials Network; Irish Critical Care Trials Group, et al.Timing of initiation of renal-replacement therapy in acute kidney injury.N Engl J Med. 2020;383:240-251. doi: 10.1056/NEJMoa2000741.

  10. De Simone P, Nevens F, De Carlis L, Metselaar HJ, Beckebaum S,Saliba F, et al. Everolimus with reduced tacrolimus improves renalfunction in de novo liver transplant recipients: a randomized controlledtrial. Am J Transplant. 2012;12:3008-3020. doi: 10.1111/j.1600-6143.2012.04212.x.




2020     |     www.medigraphic.com